Role of m6A modification in Alpha 1-antitrypsin deficiency induces liver disease
Role of m6A modification in Alpha 1-antitrypsin deficiency induces liver disease
批准号:
10188931
负责人:
Juncheng Wei
金额:
$22.81万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-01 至 2023-05-31
关键词:
5&apos Untranslated RegionsATF6 geneAddressAdenosineApoptosisApoptoticAttenuatedBiologicalCell DeathChildChildhoodChronicCirrhosisClinicalDevelopmentEndoplasmic ReticulumFDA approvedFibrosisFunctional disorderGenesGeneticGenetic TranscriptionGenetic TranslationHealthHepaticHepatotoxicityIncidenceInfantInflammationInheritedInjuryKnock-outLinkLiverLiver FailureLiver diseasesMeasuresMediatingMessenger RNAMetabolicMethylationMethyltransferaseMissionMitochondriaModificationMolecularMusMutationNational Institute of Child Health and Human DevelopmentNuclear ExportObesityOutcomePathway interactionsPharmaceutical PreparationsPhenotypePolymersPopulationProteinsRNA SplicingRegulationRoleSignal PathwaySite-Directed MutagenesisStressTestingTherapeuticToxic effectTranslatingTranslationsalpha 1-Antitrypsinalpha 1-Antitrypsin Deficiencycarcinogenesisdesigndisorder preventionearly childhoodentacaponeepidemiology studyimprovedliver injuryliver transplantationmisfolded proteinmouse modelmutantnon-alcoholic fatty liver diseasenovelnovel therapeutic interventionprotein degradationprotein expressionprotein foldingproteotoxicityresponsetraittranscription factortranscription factor CHOP
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Alpha1-antitrypsin deficiency (AATD) is the most common genetic cause of liver disease in
children and the most frequent inherited indication for liver failure and transplantation in the
pediatric population. However, the clinical course of AATD-related liver disease is highly variable.
The majority of infants with homozygous severe AATD (PiZZ) clinically recover in early childhood
through the unknown adaptive mechanisms. Epidemiological studies give rise to three
outstanding questions in the field. They are: (1) What are the mechanisms of adaptation to the
misfolded AAT accumulation in the lumen of ER? (2) Do the mechanisms of adaptation only
response to misfolded AAT or also target other unfolded proteins? and (3) Can we design
therapeutic strategies to directly use these mechanisms of adaptation? Here, we identified a novel
alpha1-antitrypsin deficiency adaptive mechanism, ER proteotoxic stress-m6A pathway or ERm6A
: Unfolded Alpha1-antitrypsin protein accumulation induces N6-adenosine-methyltransferase 14
(METTL14) elevation to increase m6A mRNA methylation of C/EBP Homologous Protein (CHOP),
which suppresses CHOP translation and reduces expression of its downstream pro-apoptotic
target genes, apoptosis and liver injury. We propose that ERm6A regulates ER proteotoxic stress
at the epitranscriptional level, through a mechanism that is distinct from any other previously
described ER proteotoxic stress-associated signaling pathway, including the well-known
canonical (transcriptional and translational level) UPR pathway. We will test the central hypothesis
that METTL14, induced by unfolded protein accumulation, suppresses cell death and liver
hepatotoxicity (Aim 1.1) by modulating CHOP 5′ UTR m6A modification (Aim 1.2). This proposal
addresses the mission of the NICHD by rigorously investigating the molecular mechanisms of
AATD-induced liver injury with the potential to improve health for large numbers of children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of m6A modification in Alpha 1-antitrypsin deficiency induces liver disease
-
批准号:10408772
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2021
-
负责人:Juncheng Wei
-
依托单位:
海外基金